Merck Life Science A/S: Financial statements 2024
CVR: 20830131
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Merck Life Science A/S (CVR 20830131) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 1,536,249,249 and a net result of DKK 66,730,278 compared with DKK 73,609,980 the year before. That is an increase of 9.8% compared with the year before. The profit margin was 4.3%. Equity in the 2024 report amounted to DKK 216,585,748. The solvency ratio was 72.6%. The company had 23 employees in the financial year.
- Revenue
- DKK 1,536,249,249
- Gross Profit
- DKK 108,652,404
- Profit/Loss
- DKK 66,730,278
- Equity
- DKK 216,585,748
- Total Assets
- DKK 298,297,224
- Employees
- 23
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 1.5B | 108.7M | 66.7M | 216.6M | 23 |
| 2023 | 1.4B | 119.8M | 73.6M | 239.9M | 24 |
| 2022 | 1.3B | 80.1M | 46M | 166.2M | 20 |
| 2021 | 1B | 69.8M | 37.7M | 214.7M | 16 |
| 2020 | 768.2M | 72.1M | 41.3M | 177M | 16 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Merck Life Science A/S has published its annual report for 2023. Revenue came to DKK 1,398,642,419, and the net result was DKK 73,609,980.
About Merck Life Science A/S
Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.
